Delcath Systems, Inc., led by CEO Gerard Michel, received authorization for clinical studies in the UK and EU.
1 report, 1 independent
Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Delcath Systems, Inc., led by CEO Gerard Michel, received authorization for clinical studies in the UK and EU.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Delcath Systems, Inc.
Nothing else this week.
-
Gerard Michel
Haitian artist
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireDelcath Systems Reports Second Quarter 2025 Results and Business Highlights Conference Call Today at 8:30 a.m. Eastern Time QUEENSBURY, N.Y., August 06, 2025--(BUSINESS WIRE)--Delcath Systems, Inc. (